Stefek M, Bezek S
Xenobiotica. 1985 Oct;15(10):805-12. doi: 10.3109/00498258509045032.
The uptake and metabolism of pentacaine, a novel carbanilate local anaesthetic agent, were studied using different rat-liver preparations. Pentacaine, added to a rat-liver microsomal suspension, elicited a type-I spectrum with Ks of 2.3 microM. The Km for total metabolism of pentacaine by rat-liver microsomes was 33.5 microM and in isolated hepatocytes 19.1 microM. Good agreement was obtained between the Vmax values for both in vitro systems and for perfused rat liver. In an isolated perfused rat liver the mean extraction ratio of pentacaine was 0.99 for a single pass, but it was significantly decreased by the presence of albumin and red blood cells. The uptake of pentacaine by isolated hepatocytes was rapid and independent of drug concn. over the range 0-200 microM. The high hepatic extraction of pentacaine is probably due mostly to passive diffusion and non-specific intracellular binding; metabolic elimination is secondary and much slower than uptake. The extensive first-pass removal of free pentacaine suggests that the systemic fraction of an oral dose in vivo is derived mainly from drug bound to blood components.
使用不同的大鼠肝脏制剂研究了新型氨基甲酸酯类局部麻醉药喷他卡因的摄取和代谢。将喷他卡因添加到大鼠肝脏微粒体悬浮液中,产生了Ks为2.3微摩尔的I型光谱。大鼠肝脏微粒体对喷他卡因总代谢的Km为33.5微摩尔,在分离的肝细胞中为19.1微摩尔。两种体外系统以及灌注大鼠肝脏的Vmax值之间取得了良好的一致性。在分离的灌注大鼠肝脏中,喷他卡因单次通过的平均提取率为0.99,但白蛋白和红细胞的存在使其显著降低。分离的肝细胞对喷他卡因的摄取迅速,且在0 - 200微摩尔范围内与药物浓度无关。喷他卡因的高肝提取率可能主要归因于被动扩散和非特异性细胞内结合;代谢消除是次要的,且比摄取慢得多。游离喷他卡因的广泛首过消除表明,体内口服剂量的全身部分主要来源于与血液成分结合的药物。